Home/Entera Bio/Dr. Roger Garceau
DR

Dr. Roger Garceau

Chief Development Officer

Entera Bio

Entera Bio Pipeline

DrugIndicationPhase
EB613Osteoporosis (postmenopausal women)Phase 3
EB612HypoparathyroidismPhase 2
EBP05OsteoporosisPreclinical